Compare ADMA & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | MMSI |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | N/A | 1990 |
| Metric | ADMA | MMSI |
|---|---|---|
| Price | $16.86 | $80.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $28.50 | ★ $106.13 |
| AVG Volume (30 Days) | ★ 2.4M | 795.8K |
| Earning Date | 03-02-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 205.35 | N/A |
| EPS | 0.86 | ★ 1.95 |
| Revenue | $488,559,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $22.13 | $13.67 |
| Revenue Next Year | $24.15 | $6.16 |
| P/E Ratio | ★ $20.47 | $41.25 |
| Revenue Growth | ★ 27.63 | 11.41 |
| 52 Week Low | $13.50 | $78.12 |
| 52 Week High | $25.67 | $110.67 |
| Indicator | ADMA | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 40.00 |
| Support Level | $16.62 | $79.38 |
| Resistance Level | $18.00 | $82.28 |
| Average True Range (ATR) | 0.72 | 1.92 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 30.71 | 20.20 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.